OSIMERTINIB COUPLED WITH ERLOTINIB ALLEVIATED ACQUIRED RESISTANCE TO EGFR-TKIS MONOTHERAPY IN A PATIENT WITH EGFR P. GLU746_ALA750 DEL (E19)-MUTANT NSCLC: A CASE REPORT
Session Name
AS16 - Lung Cancer
Presentation Type
Abstract Submission